Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.56 |
| ▸ | MC4R | P32245 | 1/20 | 0.52 |
| ▸ | CALCR | P30988 | 4/20 | 0.52 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.49 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.49 |
| ▸ | NMBR | P28336 | 2/20 | 0.49 |
| ▸ | GRPR | P30550 | 2/20 | 0.49 |
| ▸ | APLNR | P35414 | 1/20 | 0.48 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.47 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.47 |
| ▸ | REN | P00797 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30272533 | 0.98 | F2 (0.56) | F2MC4RCALCRCRHR1CRHR2 | |
| SCHEMBL30272526 | 0.88 | F2 (0.58) | F2MC4RCALCRNMUR2NMUR1 | |
| SCHEMBL30272525 | 0.87 | F2 (0.56) | F2MC4RCALCRNMUR2NMUR1 | |
| SCHEMBL30165153 | 0.86 | MC4R (0.47) | F2MC4RCALCRAPLNRNMUR2 | |
| SCHEMBL30804656 | 0.86 | F2 (0.67) | F2MC4RCALCRCRHR1CRHR2 | |
| SCHEMBL31031589 | 0.85 | F2 (0.61) | F2MC4RCALCRCRHR1CRHR2 | |
| SCHEMBL31437675 | 0.85 | REN (0.53) | F2CALCRREN | |
| SCHEMBL29798291 | 0.84 | CALCR (0.54) | F2CALCRCRHR1CRHR2NMBR | |
| SCHEMBL29655695 | 0.84 | F2 (0.51) | F2 | |
| SCHEMBL29878778 | 0.83 | F2 (0.55) | F2MC4RAPLNRNMUR2NMUR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115746103-A | Preparation method of Bulevirtide | 深圳市健翔生物制药有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115746103-A | Preparation method of Bulevirtide | 深圳市健翔生物制药有限公司 | 2023-03-07 | — | — | CN | disclosed |